Activation of the phosphoinositide 3-kinase/Akt/mammalian target of rapamycin pathway (PI3K/Akt/mTOR) has been detected in AML, CML, ALL, and CLL cells. This evidence concerns the gene MTOR and chronic myelogenous leukemia, BCR-ABL1 positive.